| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |